Literature DB >> 31961918

Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.

S A Srour1, H Singh2, J McCarty1, E de Groot3, H Huls2, G Rondon1, M Qazilbash1, S Ciurea1, G Bardelli3, J Buck3, A Alousi1, Y Nieto1, K Rezvani1, D Marin1, U Popat1, C Hosing1, E J Shpall1, W G Wierda4, H Kantarjian4, R E Champlin1, L J Cooper3, P Kebriaei1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31961918     DOI： 10.1182/blood.2019002920

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity.

Authors:  Meisam Naeimi Kararoudi; Brian P Tullius; Nitin Chakravarti; Emily J Pomeroy; Branden S Moriarity; Kathie Beland; Aurelien B L Colamartino; Elie Haddad; Yaya Chu; Mitchell S Cairo; Dean A Lee
Journal:  Semin Hematol       Date:  2020-11-19       Impact factor: 3.851

Review 2.  Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.

Authors:  Moritz Ernst; Annika Oeser; Burcu Besiroglu; Julia Caro-Valenzuela; Mohamed Abd El Aziz; Ina Monsef; Peter Borchmann; Lise J Estcourt; Nicole Skoetz; Marius Goldkuhle
Journal:  Cochrane Database Syst Rev       Date:  2021-09-13

3.  Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy.

Authors:  Jaitip Tipanee; Ermira Samara-Kuko; Thierry Gevaert; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2022-06-16       Impact factor: 12.910

Review 4.  Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?

Authors:  Chiara F Magnani; Sarah Tettamanti; Gaia Alberti; Ilaria Pisani; Andrea Biondi; Marta Serafini; Giuseppe Gaipa
Journal:  Cells       Date:  2020-05-27       Impact factor: 6.600

Review 5.  Chimeric Antigen Receptor beyond CAR-T Cells.

Authors:  Vicky Mengfei Qin; Criselle D'Souza; Paul J Neeson; Joe Jiang Zhu
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

Review 6.  CAR T-Cell Production Using Nonviral Approaches.

Authors:  Viktor Lukjanov; Irena Koutná; Pavel Šimara
Journal:  J Immunol Res       Date:  2021-03-27       Impact factor: 4.818

7.  In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor.

Authors:  Hongjie Wang; Chang Li; Adebimpe O Obadan; Hannah Frizzell; Tien-Ying Hsiang; Sucheol Gil; Audrey Germond; Connie Fountain; Audrey Baldessari; Steve Roffler; Hans-Peter Kiem; Deborah H Fuller; André Lieber
Journal:  Hum Gene Ther       Date:  2022-04       Impact factor: 4.793
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.